← back to search

Alfred Sandrock

Biogen (United States) · US
Area of research
Physiology · Pathology and Forensic Medicine
Research interest
Research interests include Alzheimer's disease research and treatments, Multiple Sclerosis Research Studies, Polyomavirus and related diseases, and Cholinesterase and Neurodegenerative Diseases.
h-index
35
citations
16,938
works
87
NIH funding
primary concept
Medicine
email

Recent publications

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
The Journal of Prevention of Alzheimer s Disease 2022cited by 1,289position: lastdoi
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
CNS Drugs 2021cited by 121position: middledoi
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
New England Journal of Medicine 2020cited by 533position: middledoi
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Neuromuscular Disorders 2019cited by 618position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2022–2022)Diego Centonze · Agostino Gemelli University Polyclinic1 papers (2021–2021) · 1 papers (2021–2021)Spyros Chalkias · Meridian Clinical Research1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2021–2021)Arman Altincatal · Sanofi (United States)1 papers (2021–2021) · 1 papers (2022–2022)Karen Smirnakis · Biogen (United States)1 papers (2021–2021)Cath Mummery · UK Dementia Research Institute1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2022–2022)Ivan Nestorov · Biogen (United States)1 papers (2022–2022)Ying Zhu · Guangzhou University of Chinese Medicine1 papers (2022–2022)Oskar Hansson · Medical Research Council1 papers (2022–2022)Bruno Vellas · Hôpital de La Grave1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Frederik Barkhof · The Queen's Medical Research Institute1 papers (2022–2022)